Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus

By Derosa Giuseppe   Salvadeo Sibilla AT   Cicero Arrigo FG  

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 559-569

Future Medicine

Access to resources Recommend Favorite

A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes

By Hutchins Valerie   Zhang Bin   Fleurence Rachael L.   Krishnarajah Girishanthy   Graham John  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1157-1168

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial

By Farsang Csaba  

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 333-344

Springer Publishing Company

Access to resources Recommend Favorite

New Fixed‐Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High‐Risk Patients with Mixed Dyslipidemia Versus Monotherapies

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 6, 2015-12 ,pp. : 329-337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of diabetes‐associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 573-580

John Wiley & Sons Inc

Access to resources Recommend Favorite